These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 17393436

  • 1. A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis.
    Saito H, Kojima T, Takahashi M, Horne WC, Baron R, Amagasa T, Ohya K, Aoki K.
    Arthritis Rheum; 2007 Apr; 56(4):1164-74. PubMed ID: 17393436
    [Abstract] [Full Text] [Related]

  • 2. Subcutaneous injections of a TNF-alpha antagonistic peptide inhibit both inflammation and bone resorption in collagen-induced murine arthritis.
    Kojima T, Aoki K, Nonaka K, Saito H, Azuma M, Iwai H, Varghese BJ, Yoshimasu H, Baron R, Ohya K, Amagasa T.
    J Med Dent Sci; 2005 Mar; 52(1):91-9. PubMed ID: 15868746
    [Abstract] [Full Text] [Related]

  • 3. A tumor necrosis factor-alpha antagonist inhibits inflammatory bone resorption induced by Porphyromonas gingivalis infection in mice.
    Suzuki Y, Aoki K, Saito H, Umeda M, Nitta H, Baron R, Ohya K.
    J Periodontal Res; 2006 Apr; 41(2):81-91. PubMed ID: 16499710
    [Abstract] [Full Text] [Related]

  • 4. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegård D, van den Berg WB.
    Arthritis Res; 1999 Apr; 1(1):81-91. PubMed ID: 11056663
    [Abstract] [Full Text] [Related]

  • 5. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
    Joosten LA, Helsen MM, van de Loo FA, van den Berg WB.
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
    [Abstract] [Full Text] [Related]

  • 6. TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis.
    Saidenberg-Kermanac'h N, Corrado A, Lemeiter D, deVernejoul MC, Boissier MC, Cohen-Solal ME.
    Bone; 2004 Nov; 35(5):1200-7. PubMed ID: 15542046
    [Abstract] [Full Text] [Related]

  • 7. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB.
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [Abstract] [Full Text] [Related]

  • 8. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J, Hayer S, Tohidast-Akrad M, Bergmeister H, Redlich K, Feige U, Dunstan C, Kollias G, Steiner G, Smolen J, Schett G.
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [Abstract] [Full Text] [Related]

  • 9. Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction.
    Zwerina J, Hayer S, Redlich K, Bobacz K, Kollias G, Smolen JS, Schett G.
    Arthritis Rheum; 2006 Feb; 54(2):463-72. PubMed ID: 16447221
    [Abstract] [Full Text] [Related]

  • 10. Treatment with anti-gamma-glutamyl transpeptidase antibody attenuates osteolysis in collagen-induced arthritis mice.
    Ishizuka Y, Moriwaki S, Kawahara-Hanaoka M, Uemura Y, Serizawa I, Miyauchi M, Shibata S, Kanaya T, Takata T, Taniguchi N, Niida S.
    J Bone Miner Res; 2007 Dec; 22(12):1933-42. PubMed ID: 17680722
    [Abstract] [Full Text] [Related]

  • 11. Reduction in the evolution of murine type II collagen-induced arthritis by treatment with rosiglitazone, a ligand of the peroxisome proliferator-activated receptor gamma.
    Cuzzocrea S, Mazzon E, Dugo L, Patel NS, Serraino I, Di Paola R, Genovese T, Britti D, De Maio M, Caputi AP, Thiemermann C.
    Arthritis Rheum; 2003 Dec; 48(12):3544-56. PubMed ID: 14674008
    [Abstract] [Full Text] [Related]

  • 12. THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritis.
    Tomita T, Kakiuchi Y, Tsao PS.
    Arthritis Res Ther; 2006 Dec; 8(1):R7. PubMed ID: 16356194
    [Abstract] [Full Text] [Related]

  • 13. Suppressive effects of Chelidonium majus methanol extract in knee joint, regional lymph nodes, and spleen on collagen-induced arthritis in mice.
    Lee YC, Kim SH, Roh SS, Choi HY, Seo YB.
    J Ethnopharmacol; 2007 May 30; 112(1):40-8. PubMed ID: 17353105
    [Abstract] [Full Text] [Related]

  • 14. Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models.
    Schett G, Middleton S, Bolon B, Stolina M, Brown H, Zhu L, Pretorius J, Zack DJ, Kostenuik P, Feige U.
    Arthritis Rheum; 2005 May 30; 52(5):1604-11. PubMed ID: 15880601
    [Abstract] [Full Text] [Related]

  • 15. Adrenomedullin(22-52) combats inflammation and prevents systemic bone loss in murine collagen-induced arthritis.
    Ah Kioon MD, Asensio C, Ea HK, Velard F, Uzan B, Rullé S, Bazille C, Marty C, Falgarone G, Nguyen C, Collet C, Launay JM, Cohen-Solal M, Lioté F.
    Arthritis Rheum; 2012 Apr 30; 64(4):1069-81. PubMed ID: 22006509
    [Abstract] [Full Text] [Related]

  • 16. Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis.
    Schett G, Stolina M, Dwyer D, Zack D, Uderhardt S, Krönke G, Kostenuik P, Feige U.
    Arthritis Rheum; 2009 Sep 30; 60(9):2644-54. PubMed ID: 19714640
    [Abstract] [Full Text] [Related]

  • 17. Effect of tumor necrosis factor-related apoptosis-inducing ligand on the reduction of joint inflammation in experimental rheumatoid arthritis.
    Jin CH, Chae SY, Kim TH, Yang HK, Lee EY, Song YW, Jo DG, Lee KC.
    J Pharmacol Exp Ther; 2010 Mar 30; 332(3):858-65. PubMed ID: 19933369
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-1beta and tumor necrosis factor-alpha produce distinct, time-dependent patterns of acute arthritis in the rat knee.
    Bolon B, Campagnuolo G, Zhu L, Duryea D, Zack D, Feige U.
    Vet Pathol; 2004 May 30; 41(3):235-43. PubMed ID: 15133172
    [Abstract] [Full Text] [Related]

  • 19. Suppressive effect of hochu-ekki-to on collagen induced arthritis in DBA1J mice.
    Hai le X, Kogure T, Niizawa A, Fujinaga H, Sakakibara I, Shimada Y, Watanabe H, Terasawa K.
    J Rheumatol; 2002 Aug 30; 29(8):1601-8. PubMed ID: 12180716
    [Abstract] [Full Text] [Related]

  • 20. Anti-arthritic properties of FK506 on collagen-induced arthritis in rats.
    Magari K, Nishigaki F, Sasakawa T, Ogawa T, Miyata S, Ohkubo Y, Mutoh S, Goto T.
    Inflamm Res; 2003 Dec 30; 52(12):524-9. PubMed ID: 14991082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.